Citigroup Inc (NYSE:C) CEO Barbara Desoer bought 1,000 shares of the company’s stock on the open market in a transaction that occurred on Tuesday, April 15th. The shares were purchased at an average price of $48.19 per share, for a total transaction of $48,190.00. Citigroup Inc (NYSE:C) shares after opening at $48.45moved to $48.58 on last trade day and at the end of the day closed at $48.33. Company price to sales ratio in past twelve months was calculated as 2.35 and price to cash ratio as 0.20. Citigroup Inc (NYSE:C) showed a positive weekly performance of 0.31%.
American Realty Capital Properties Inc (NASDAQ:ARCP) Director Edward M. Jr. Weil bought 7,500 shares of the company’s stock on the open market in a transaction dated Monday, April 21st. The shares were purchased at an average price of $13.28 per share, with a total value of $99,600.00. American Realty Capital Properties Inc (NASDAQ:ARCP) shares fell -0.23% in last trading session and ended the day on $13.21. ARCP return on equity ratio is recorded as -31.80% and its return on assets is -11.90%. American Realty Capital Properties Inc (NASDAQ:ARCP) yearly performance is -13.77%.
Alliqua major shareholder Celgene Corporation (NASDAQ:CELG) bought 714,286 shares of the company’s stock in a transaction that occurred on Monday, April 14th. The stock was purchased at an average cost of $7.00 per share, with a total value of $5,000,002.00. Celgene Corporation (NASDAQ:CELG) shares moved down -2.47% in last trading session and was closed at $141.25 while trading in range of $136.75 – $142.49- Celgene Corporation (NASDAQ:CELG) year to date (YTD) performance is -16.41%.
Inovio Pharmaceuticals Inc (NYSE:INO) CEO Jong Joseph Kim bought 25,000 shares of the company’s stock in a transaction dated Tuesday, April 15th. The shares were purchased at an average price of $2.25 per share, for a total transaction of $56,250.00. Inovio Pharmaceuticals Inc (NYSEMKT:INO) weekly performance is -2.62%. On last trading day company shares ended up $2.60. Inovio Pharmaceuticals Inc (NYSEMKT:INO) distance from 50-day simple moving average (SMA50) is -18.95%. Analysts mean target price for the company is $4.60.
Leave a Reply